ATRC
AtriCure Inc
NASDAQ: ATRC · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$61.42
-0.15% today
Updated 2026-10-28
Market cap
$3.12B
P/E ratio
292.48
P/S ratio
5.48x
EPS (TTM)
$0.21
Dividend yield
—
52W range
$25 – $63
Volume
1.1M
AtriCure Inc (ATRC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$61.42
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$74.35
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.3B | $0.3B | $0.4B | $0.5B | $0.5B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 1.85%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.